Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 78.61B | 78.56B | 29.02B | 26.26B | 26.91B | 22.23B |
Gross Profit | 30.77B | 28.28B | 29.64B | 25.95B | 26.91B | 25.02B |
EBITDA | 13.55B | 11.18B | 7.71B | 19.00B | 11.44B | 7.61B |
Net Income | 8.72B | 7.32B | 4.42B | 13.54B | 7.75B | 5.10B |
Balance Sheet | ||||||
Total Assets | 1.43T | 1.41T | 1.29T | 1.14T | 988.17B | 949.26B |
Cash, Cash Equivalents and Short-Term Investments | 169.21B | 113.53B | 114.31B | 118.21B | 121.97B | 95.24B |
Total Debt | 394.00B | 262.44B | 248.74B | 222.64B | 189.81B | 187.01B |
Total Liabilities | 1.34T | 1.33T | 1.22T | 1.07T | 930.65B | 892.67B |
Stockholders Equity | 86.72B | 84.25B | 77.01B | 71.04B | 57.52B | 56.59B |
Cash Flow | ||||||
Free Cash Flow | 518.00M | 27.47B | 19.59B | 3.51B | 43.07B | 49.80B |
Operating Cash Flow | 2.18B | 29.03B | 21.27B | 4.96B | 44.05B | 50.84B |
Investing Cash Flow | -5.94B | -24.53B | -21.16B | -29.47B | -299.00M | -31.97B |
Financing Cash Flow | -12.02B | -17.41B | 268.00M | 15.98B | 47.12B | -10.30B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | C$104.51B | 13.52 | 12.99% | 3.45% | -0.39% | 20.28% | |
78 Outperform | C$59.06B | 14.63 | ― | 3.08% | 9.25% | 0.34% | |
77 Outperform | $93.62B | 15.92 | 10.20% | 3.48% | 15.63% | 66.95% | |
75 Outperform | C$286.10B | 15.37 | 14.13% | 2.91% | 3.48% | 17.81% | |
74 Outperform | C$188.39B | 9.44 | 16.66% | 3.78% | 7.92% | 175.59% | |
71 Outperform | C$111.51B | 16.72 | ― | 6.08% | -2.54% | -6.66% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |